Overview

Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.

Status:
Completed

Trial end date:
2014-07-01

Target enrollment:

Participant gender:

Summary

To evaluate the efficacy and safety of diazepam in the management of refractory epilepsy in selected patients who require intermittent medical intervention for the control of episodes of acute repetitive seizures. In addition, to assess the support provided by caregivers who are not themselves or not under the direct supervision of health care professionals at the time of administration.

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Diazepam